Abstract
Statistics on a relatively small number of cases of pneumococcus pneumonia in San Francisco have been presented. While our statistical data are small, it is in accord with the figures presented in larger series. There has been a constant reduction in mortality rate consistent with the introduction of newer therapeutic agents. Complications may be less and certainly the consequences of complications are less severe with the employment of the newer drugs. The high mortality rate formerly accompanying the positive blood culture have been drastically reduced by the use of these newer drugs. We must not overlook the fact that marked variations in the severity of infection and variation in morbidity influence the statistics in pneumococcus pneumonia to a large extent.
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have
Schedule a callDisclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.
